• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mini Rev Med Chem . A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19

tetano

Editor, Senior Moderator
Mini Rev Med Chem


. 2021 Jan 4.
doi: 10.2174/1389557521666210104165733. Online ahead of print.
A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19


Maheswara Rao Gokada[SUP] 1 [/SUP], Visweswara Rao Pasupuleti[SUP] 2 [/SUP], Hari Babu Bollikolla[SUP] 1 [/SUP]



Affiliations

Abstract

The novel Coronavirus disease (COVID-19) is an epidemic disease which appeared at the end of the year 2019 in a sudden increase in number and considered as a pandemic disease caused by a viral infection and it has threatened most countries towards the emergency search for new anti-SARS-COV drugs /vaccines. At present, the number of clinical trials is ongoing worldwide on different drugs i.e. Hydroxychloroquine, Remedisvir, Favipiravir that utilizes various mechanisms of actions. A few world countries are currently processing for clinical trials which may result in a positive manner. Favipiravir (FPV) represents one of the feasible treatment options for COVID-19, if trials result seems positive. Favipiravir will be one among the developed authoritative possible drugs to warrant the benefits to mankind with large-scale production in order to meet the demands by the current pandemic Covid-19 outbreak and the future epidemic outbreaks. In this review, the authors tried to explore key molecules, which will be supportive for scheming COVID-19 research.

Keywords: COVID-19.; Coronavirus; Favipiravir; Hydroxychloroquine; Mechanism of action; Remedisvir.
 
Back
Top Bottom